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In patients with a renal stone, management aims to detect complications, 
triage to expectant observation or active intervention and identify any 
predisposing factors. Referral for active urological intervention or detailed 
metabolic evaluation may be indicated. Dietary and lifestyle interventions 
may help decrease the risk of recurrences.
R
enal stones are common and are asso-
ciated with significant morbidity and, 
on rare occasions, mortality when the 
stone obstructs the urinary tract in the 
presence of infected urine. Common adverse 
impacts of  renal stones (calculi) include not 
only pain but also the need for GP or emer-
gency department visits for pain relief or 
intervention, surgical procedures, follow-up 
reviews and time lost from work. Renal stones 
are associated with an increased risk of 
chronic renal disease. In addition, people who 
develop renal stones are at increased risk of 
cardiovascular events, hypertension, diabetes 
and the  metabolic syndrome. For those with 
recurrent stone disease, the risks associated 
with repeated radiation exposure from imag-
ing studies must also be considered. 
Lifestyle factors can contribute to the risk 
of stone formation, and addressing these may 
reduce recurrences. Some patients, however, 
have more complex metabolic abnormalities 
or underlying medical conditions that may 
require specific management by renal physi-
cians or urologists with a special interest in 
this area. This article discusses the approach 
to evaluation, treatment and referral of 
patients with renal stones in general practice. 
It will not address surgical management in 
detail.
Key points
• In patients with a suspected 
renal stone, history taking, 
examination and investigation 
aim to confirm the diagnosis 
and detect any complica­
tions, such as sepsis or renal 
damage, and underlying 
factors that increase the 
risk of recurrence.
• Options for treatment of 
renal stones include 
expectant observation if the 
patient has good renal 
function, well­controlled 
pain and no evidence of 
sepsis, or a need for active 
urological intervention.
• Urinary tract infection in the 
presence of obstruction is a 
medical and surgical 
emergency, requiring 
immediate relief of the 
obstruction. 
• Factors that contribute to 
renal stone formation 
should be addressed to 
prevent further stones; the 
most important lifestyle 
interventions are increased 
water intake and reduced 
protein and sodium intake. 
MedicineToday 2015; 16(2): 45-52 
PEER REVIEWED FEATURE
2 CPD POINTS  
Dr Qadri is a Renal Advanced Trainee at The Wollongong Hospital, Wollongong. Professor Lonergan is Director of 
the Illawarra Shoalhaven Local Health District Renal Service, The Wollongong Hospital, Wollongong. Ms Lambert is 















First steps and keys to
reducing recurrence
Renal stones 
MedicineToday   x   FEBRUARY 2015, VOLUME 16, NUMBER 2    45
Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2015.
Copyright _Layout 1  17/01/12  1:43 PM  Page 4
EPIDEMIOLOGY
Renal stones range from asymptomatic 
small stones to large, obstructing staghorn 
calculi that impair renal function and 
cause chronic kidney disease (Figures 1a 
and b). The presence of renal stone disease 
of any kind increases the risk of chronic 
renal impairment.
Estimates of the incidence of renal 
stone disease vary between populations; 
in the USA, an estimated 12% of men and 
5% of women will have a renal stone that 
causes symptoms by the age of 70 years. 
The overall incidence of renal stone dis-
ease, as well as the proportion of females 
affected, are reported to be increasing, 
probably related to changes in diet and 
lifestyle. The incidence also varies with 
geography, climate and seasonal factors, 
with a higher incidence in hotter drier 
environments, related to the greater risk 
of dehydration.1,2
Australian data on the incidence of 
renal stones are limited. A study using the 
Western Australia Linked Database 
reported that between 1980 and 1997 
almost 17,000 patients were admitted to 
hospital after a first presentation with a 
principal condition relating to renal or 
ureteric stones.3 The mean age was 
48 years (range, 1 to 95 years), and 70% 
were males. More than half the patients 
were admitted as emergency cases, and 
55% underwent at least one surgical 
 intervention, with almost a quarter 
undergoing multiple procedures by 
 mid-1999. There were more than 12,000 
hospital readmissions, almost half for 
recurrence of upper urinary tract stones. 
The locations of the renal stones were in 
the ureter alone (54%), in the kidney alone 
(42%) and in several sites involving both 
the kidney and ureter (4%). 
Small Australian case series report an 
increased incidence of renal stones in 
 children in rural and remote areas related 
to diet and dehydration as well as chronic 
metabolic acidosis complicating diarrhoeal 
illnesses.4,5 
The risk of recurrence of renal stones 
has been estimated as 50% within 10 years. 
Males have a higher recurrence rate than 
females. The risk of repeat stones is highest 
in the year immediately after the first 
 episode. For calcium stones, the risk of a 
second stone has been reported to be 15% 
at one year, 35 to 40% at five years and 80% 
at 10 years.
Observational studies have linked renal 
stones with diabetes, hypertension, obe-
sity, hyperuricaemia, hyperlipidaemia, 
chronic kidney disease and cardiovascular 
disease. A 2014 meta-analysis of cohort 
studies concluded that kidney stones are 
a risk factor for both stroke and coronary 
heart disease.6 The risk of an adverse 
 cardiovascular event may be higher for 
women than men, but long-term prospec-
tive studies are needed to investigate the 
sex-specific association.
AETIOLOGY OF RENAL STONES 
Renal stones develop when crystals form in 
the urine and subsequently grow. This occurs 
when the urine becomes supersaturated with 
salts such as calcium oxalate, sodium urate, 
magnesium ammonium phosphate or 
 cystine (i.e. the amount of the salt exceeds 
its solubility). Crystals can also form when 
concentrations of inhibitors to crystallisa-
tion are low or matrix (a mucoprotein) is 
present.7 Inhibitors of crystallisation include 
citrate,  magnesium, zinc and pyrophos-
phate, as well as the glycoproteins nephro-
calcin and Tamm–Horsfall protein.
The risk of stone formation can be 
reduced by modifying the concentration 
or solubility of the crystallising substance. 
Manipulation of risk factors is crucial to 
preventing recurrent stone formation. 
Patients may have one or multiple factors 
contributing to stone formation. 
Renal stones are most commonly 
 composed of calcium, generally combined 
with oxalate but also phosphate. Calcium 
stones may occur with the following 
 abnormalities, alone or in combination: 
• hypercalciuria with or without 
hypercalcaemia
• hyperuricosuria (uric acid acts as the 
nidus for the stone formation)
• hypocitraturia 
• hyperoxaluria
• low urine volume.
Other types of renal stones are composed 
of uric acid, struvite (magnesium ammo-
nium phosphate, sometimes termed infec-
tion or triple phosphate stones, which form 
in the presence of urea-splitting micro-or-
ganisms), cystine or a mixture (calcium, 
oxalate and urate). A NSW study of upper 
urinary stones submitted for analysis 
between 2009 and 2011 found they were 
composed of  calcium oxalate (64%), uric 
acid (16%) or struvite (7%).8 The peak inci-
dence of struvite stones was in men aged 
61 to 70 years.
Medical conditions and medications 
associated with an increased risk of stone 
formation are listed in Box 1. Lifestyle 
 factors that increase the risk of renal stones 
are discussed below.
Figures 1a and b. a (above). Renal  
stones (scale in cm). b (right). Radiograph 
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PRESENTATION
The typical presentation of renal stones is 
sudden onset of unilateral flank pain that 
radiates to the groin. However, many renal 
stones are asymptomatic and are inciden-
tal findings during imaging for other 
indications. 
When pain occurs, it typically waxes and 
wanes in intensity, lasting 20 to 60 minutes, 
with a dull pain between bouts of the colicky 
pain. As the stone moves down the ureter, 
the pain shifts to the abdomen and ipsilateral 
groin, and as it nears the ureterovesicular 
junction, the pain is characteristically in the 
lower quadrant, radiating to the tip of the 
urethra, and associated with urinary 
urgency, frequency and dysuria. Macro-
scopic  haematuria may occur but its absence 
does not exclude renal stone disease. Patients 
may have nausea and vomiting. 
DIAGNOSIS AND INVESTIGATION
History taking, examination and investi-
gation aim to confirm the diagnosis and 
to detect any complications, such as sepsis 
or renal damage, and underlying factors 
that increase the risk of renal stones. 
On examination, patients appear dis-
tressed, writhing on the examination table 
in attempts to find a comfortable position. 
Abdominal examination may reveal 
 tenderness in the costovertebral angle or 
lower quadrant. Patients may also appear 
pale and clammy. The presence of fever 
suggests infection. Signs of peritoneal 
 irritation suggest an alternative diagnosis. 
Intra- abdominal pathology that can mimic 
renal colic includes abdominal aortic 
 aneurysm, diverticulitis, appendicitis and 
gynaecological pathology (Box 2).
The extent of evaluation for patients 
presenting with a single first stone is 
debated. History taking should include 
enquiry about underlying medical condi-
tions, medications and supplements that 
increase the risk of stone formation, as well 
as lifestyle factors (see below). Onset in 
childhood and a strong family history 
suggest that investigation for specific 
 metabolic disorders is indicated. 
Blood and urine tests
All patients with a renal stone should have 
at least a limited biochemical ‘work up’, as 
outlined in Box 3, to identify any factors 
that increase the risk of stone recurrence, 
such as primary hyperparathyroidism. In 
addition, a midstream urine specimen 
should be sent for microscopy and culture, 
particularly looking for infection and the 
presence of urease-splitting organisms. 
Urine microscopy may also reveal crystals. 
Urine pH should be measured; a pH greater 
2. DIFFERENTIAL DIAGNOSES FOR 
RENAL COLIC 
Gynaecological













• Small bowel obstruction
Urological
• Pyelonephritis
• Urinary tract infection
Vascular
• Abdominal aortic aneurysm
• Aortic dissection
• Renal artery thrombosis
• Renal infarction
• Mesenteric artery dissection or 
embolism
• Intraperitoneal or retroperitoneal 
haemorrhage 
Musculoskeletal
• Mechanical low back pain
• Fractures
Other
• Herpes zoster (shingles)
1. MEDICAL CONDITIONS THAT INCREASE RISK OF RENAL STONE 
FORMATION
Increased absorption of oxalate from 
the gastrointestinal tract 
• Short bowel syndrome
• Chronic diarrhoea
• Past bowel surgery
• Jejunoileal bypass surgery
• Inflammatory bowel disease (Crohn’s 
disease, ulcerative colitis)
Increased risk of urinary tract 
infections
• Spinal cord injury
Increased urinary calcium excretion
• Primary hyperparathyroidism
• Sarcoidosis
Increased uric acid production















• Tubular ectasia – medullary sponge 
kidney
• Pelviureteric junction obstruction 




• Long-term indwelling catheters
MedicineToday   x   FEBRUARY 2015, VOLUME 16, NUMBER 2    47
Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2015.
Copyright _Layout 1  17/01/12  1:43 PM  Page 4
than 7.5 suggests stone formation is 
 associated with infection. A low serum 
bicarbonate level may indicate an under-
lying type 1 renal tubular acidosis.
Renal imaging
Patients with a history of kidney stones 
who present with typical symptoms and 
no signs of complications and have uro-
logical follow up arranged may be managed 
conservatively, with imaging undertaken 
if this management fails. Patients pre-
senting with the first onset of symptoms 
suggesting a renal stone, infection or atyp-
ical signs and those who do not improve 
with conservative management should 
have renal imaging.
A CT scan of the kidney, ureters and 
bladder (CT KUB) is the preferred option 
for most patients undergoing renal imaging 
as it can detect all stone types, including 
uric acid stones, which are radiolucent and 
thus not visible on a plain x-ray KUB. For 
pregnant women with renal stones, an 
ultrasound examination is preferred but 
does not adequately image the ureters. MRI 
may also be used in pregnancy. 
For patients with recurrent renal stones, 
the radiation exposure from repeated imag-
ing must be considered. A 2011 study in 
Victoria of 58 consecutive patients under-
going surgery for urinary tract stone 
 disease found that at least 44% had been 
exposed to high levels of radiation over the 
preceding year, mainly related to repeated 
CT scans. The authors concluded that there 
was a possible long-term increase in the 
risk of cancer.9
Analysis of stone composition
Analysis of the composition of renal stones 
is essential to determine appropriate 
 long-term treatment. Stones should be 
retrieved for analysis when possible, either 
at the time of surgical intervention or by 
having patients recover stones passed 
spontaneously.
Practice tip
• Suggest that patients pass urine into 
a container and then strain the urine. 
TREATMENT OF RENAL STONES
Expectant observation
Nonsurgical management of renal colic 
involves waiting for the spontaneous 
 passage of a stone. Nonsurgical manage-
ment may be appropriate for patients with:
• no evidence of sepsis
• good renal function and 
• well-controlled pain.
Pain management should be individu-
alised. NSAIDs and opiates are equally 
effective in the short term. However, 
NSAIDs should be avoided in anyone with 
impaired renal function or volume 
depletion.
A 10- to 14-day trial of tamsulosin has 
been recommended for patients with renal 
colic being managed with expectant 
 observation but is not PBS-listed for this 
indication.10 Calcium channel blockers may 
also be of use but are less effective than 
tamsulosin.10
Patients undergoing expectant observa-
tion should be instructed to seek prompt 
review if they develop fever,  persistent 
 vomiting or uncontrolled pain. Urological 
follow up must be in place.  Follow-up 
 imaging is required to ensure that the stone 
has passed. 
Expectant observation is undertaken 
for up to two weeks. Patients who fail to 
pass a stone within two weeks require active 
urological intervention.  
Active urological intervention
Indications for active urological interven-
tion include:
• stone diameter of 7 mm or more
• pain not controlled
• obstruction associated with infection 
(as there is a risk of pyonephrosis or 
urosepsis)
• bilateral obstruction or obstruction 
of a single kidney
• pregnancy (see below).
Obstruction of the urinary tract in the 
presence of infection is a medical and 
 surgical emergency. If there is sepsis or a 
risk of sepsis then immediate relief of the 
obstruction by insertion of a retrograde 
ureteric stent or radiographic insertion of 
a percutaneous nephrostomy is essential. 
After percutaneous nephrostomy, an ante-
grade ureteric stent may be inserted. A 
stent is also required to relieve a  urinary 
tract obstruction in pregnant women, with 
definitive intervention undertaken after 
delivery. A detailed  discussion of the uro-
logical management of renal stones is not 
included in this article. 
Primary hyperparathyroidism compli-
cated by renal stone disease is best treated 
with surgical removal of the adenoma or 
adenomas. 
PREVENTING RECURRENCES
Referral for specialised 
evaluation and management 
Some patients with renal stones require a 
more detailed metabolic evaluation, which 
is generally undertaken by a renal physician 
or urologist with a specific interest in renal 
stone disease or a specialised renal stone 
clinic. The indications for referral for a 
more detailed metabolic evaluation are 
listed in Box 4. 
Analysis of a 24-hour urine collection, 
in addition to serum biochemistry and 
urine pH, must be undertaken when the 
patient has recovered from an acute event 
3. LIMITED EVALUATION OF A 
PATIENT AFTER A FIRST RENAL 
STONE
• Blood tests
 – Urea, electrolytes, creatinine levels
 – Calcium and phosphate levels
 – Uric acid level
 – Parathyroid hormone level 
• Urine tests
 – Midstream urine microscopy, 
culture and sensitivity
 – Urinary pH 
• Renal imaging with CT of the 
kidneys, ureter and bladder 
(ultrasound or MRI if the patient  
is pregnant)
• Analysis of renal stone composition
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or intervention such as lithotripsy, generally 
after two to three months. Patients should 
collect their urine as outpatients, while 
consuming their usual diet and fluid intake. 
The crucial need to maintain their usual 
fluid intake and diet should be emphasised 
to patients; unfortunately, some people 
modify (and generally increase) their fluid 
intake while collecting the 24-hour urine, 
which may obscure the key metabolic risk 
factors for stone formation. 
The number of 24-hour collections 
required for a full metabolic evaluation 
varies. Although some laboratories are able 
to undertake a full evaluation on a single 
24-hour urine collection, most commercial 
laboratories require multiple collections, 
which becomes a significant burden and 
practical challenge for patients.
Evaluation in a specialised stone clinic 
also involves a dietitian taking a detailed 
diet history, estimating intake of protein, 
sodium, oxalate, calcium and other  dietary 
components, and providing specific 
 dietary advice on foods to avoid or 
minimise. 
Medical management to help prevent 
stone recurrence in patients with specific 
stone types and metabolic abnormalities 
is summarised in Box 5. Patients with 
recurrent calcium stones may have multiple 
metabolic abnormalities, which require a 
more complex combination of therapy to 
prevent stone formation, such as a thiazide 
diuretic, allopurinol, potassium citrate and 
a high fluid intake. 
Struvite stones require specialised 
 management. Effective treatment of stru-
vite stones requires removal of all stone 
material and treatment, if possible, of the 
chronic urinary tract infection, usually 
caused by a urea-splitting organism such 
as Proteus or Klebsiella spp. This may be 
extremely difficult, if not impossible, in 
patients with a long-term indwelling 
catheter. 
Advice on lifestyle factors 
Lifestyle factors that affect the risk of stone 
formation and some practice tips to min-
imise the risk of recurrence are discussed 
below and summarised in Box 6.
Fluid intake and types consumed 
A high fluid intake (more than 2.5 L/day) 
decreases the risk of recurrent stones of all 
types and is the most important lifestyle 
intervention to prevent recurrence. 
Patients with cystine stones require an 
even higher urine volume, of more than 
4 L/day. 
The impact of tea, coffee and alcohol 
on renal stones remains unclear. It is 
known that caffeine interferes with the 
action of antidiuretic hormone (ADH), 
decreasing urine concentration and 
increasing urine flow. However, black tea 
may be high in oxalate and ideally should 
have milk added to bind the oxalate and 
limit its absorption via the gut.11 Epide-
miological studies suggest that drinking 
one cup (240 mL) of coffee (caffeinated or 
decaffeinated) or tea daily may help pro-
tect against renal stones in healthy 
individuals.12,13 
Alcohol may protect against stone for-
mation by inhibiting secretion of ADH, 
decreasing urinary concentration. Wine 
appears to be more protective than beer, 
but both are significant sources of calories, 
and prevention of obesity is likely to have 
a greater impact on stone prevention. 
 Alcohol should only be consumed in 
 recommended amounts – not more than 
two standard drinks per day for men and 
one for women, with at least two alcohol- 
free days a week. Avoiding alcohol intake 
may be of benefit to people who develop 
uric acid stones. 
4. INDICATIONS FOR REFERRAL 
FOR MORE DETAILED METABOLIC 
EVALUATION
• Presence of multiple renal stones
• Recurrent renal stones 
• Strong family history of renal stones 
• Onset in childhood
• Intestinal disease (particularly 
chronic diarrhoea) 
• History of urinary tract infection  
with stones 
• Frail or poor health (unable to 
tolerate repeat stone episodes) 
• Solitary kidney 
• Anatomical abnormalities 
• Renal insufficiency
• Stones composed of cystine, uric 
acid or struvite
• Pathological skeletal fractures
• Osteoporosis 
5. MEDICAL MANAGEMENT OF 
PATIENTS WITH RENAL STONES 
ACCORDING TO STONE TYPE AND 
METABOLIC ABNORMALITIES*
Calcium stones with hypercalciuria




• Low sodium diet
Hyperoxaluria
• Cholestyramine 
• Vitamin B6 
low urinary citrate
• Potassium citrate (sodium bicarbonate 
may be used for patients who  
cannot tolerate potassium citrate, 
but the increase in urinary sodium 
also increases calcium excretion)
Hyperuricosuria
• Allopurinol
• Potassium citrate 
Cystine stones
• High fluid intake
• Urinary alkalinisation
• Tiopronin, D-penicillamine or 
captopril (sulfhydryl group donors) 
struvite stones 
• Urological intervention (required)
• Treatment and prevention of urinary 
tract infections
• Surgery with complete removal of 
stone
* Determined by 24-hour urine collection.
MedicineToday   x   FEBRUARY 2015, VOLUME 16, NUMBER 2    49
Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2015.
Copyright _Layout 1  17/01/12  1:43 PM  Page 4
Practice tips 
• The most effective and simple  
intervention to prevent recurrent 
renal stones is to ensure patients 
have a high intake of fluid (ideally 
water) that  maintains a urine output 
of at least 2 L/day  (ideally aiming for 
2.5 to 3.0 L/day).14 
• Failure of patients to increase their 
urine output has been found to be a 
strong predictor for recurrent stone 
formation in patients followed up in 
a dedicated stone clinic. 
• Fluids that appear from observational 
studies to increase the risk of stone 
recurrence include:
 – soft drinks rich in phosphoric acid, 
such as cola drinks; phosphoric 
acid reduces urinary citrate and 
thus binding of oxalate15
 – cranberry juice, more than 
1000 mL/day; this volume of 
 cranberry juice decreases urinary 
pH and increases urine calcium 
oxalate concentration, leading to 
uric acid stone formation16 
 – apple juice
 – grapefruit juice, which increases 
the risk of recurrence via an 
unknown mechanism.17
• Fluids that may exert a protective 
effect include:
 – lemon juice (120 mL/day, mixed 
with water), which is rich in citrate 18
 – milk, which exerts a protective 
effect by binding oxalate in the 
gastrointestinal tract.19
Work environment and exercise 
People who work in hot conditions or 
undertake heavy physical activity that 
results in profuse sweating and decreased 
urine production have an increased risk 
of dehydration and concentrated urine. 
This favours urine supersaturation and 
crystal formation. 
Practice tip
• People in situations where they 
sweating profusely require a higher 
water intake (more than 2.5 L/day) to 
avoid  dehydration and maintain a 
high output of dilute urine. 
• Encourage patients to spread out 
their water intake over the day and 
during the night if awake. 
Sodium intake 
A high sodium intake (more than 100 mmol 
urinary sodium excretion in 24 hours) 
increases urinary calcium  excretion. Reduc-
ing sodium intake reduces urinary calcium 
excretion and the risk of stone formation 
and also increases the efficacy of thiazide 
diuretics. Higher sodium excretion 
increases uric acid  excretion and decreases 
urinary citrate concentrations.
Practice tip
• Suggestions for patients to reduce 
 dietary sodium intake include 
 choosing low-salt packaged  products 
(less than 120 mg sodium per 100 g) 
and avoiding  adding salt to food in 
cooking and at the table. 
Calcium intake 
Calcium binds with oxalate in the normal 
gastrointestinal tract. A low oral calcium 
intake increases the absorption of oxalate 
and the risk of calcium oxalate stone 
 formation. However, an excessive calcium 
intake can also increase the risk of stone 
formation. Therefore maintenance of a 
normal calcium intake as per the dietary 
guidelines is recommended. The minimum 
daily requirement for calcium is 840 mg, 
and the general recommendation for adults 
is 1000 to 1300 mg/day.
If calcium supplements are used then 
they are best taken with food. Calcium 
citrate provides additional citrate, which 
is a key inhibitor of stone formation. It acts 
by lowering urinary saturation and inhib-
iting crystallisation of calcium salts.
6. RECOMMENDED LIFESTYLE MEASURES TO REDUCE RENAL STONE 
RECURRENCES
• Ensure a high fluid intake to maintain a urine output of at least 2L/day (ideally 
aiming for 2.5 to 3.0 L/day)
• Avoid dehydration by increasing water intake if sweating profusely; spread water 
intake over the day and night if awake. 
• Reduce dietary sodium intake
• Maintain a normal calcium intake via dietary sources
• In general, reduce total protein intake and increase fruit and vegetable consumption
• For patients with uric acid stones, maintain a high fluid intake, moderate protein 
intake and no alcohol
• For patients with oxalate stones, we recommend avoiding foods high in oxalate 
and vitamin C, and consuming calcium-rich foods to bind oxalate and reduce its 
absorption
• For patients with stones caused by impaired absorption of calcium due to small 
bowel disease, supplementation with magnesium citrate may be helpful
• Note that vitamin D supplementation may be a risk factor for renal stone disease
• For patients taking a fish oil product, check the label carefully as some of these 
products contain vitamin D, which may contribute to stone formation
• For patients who have a recurrence of renal stones while taking any herbal or other 
botanical-based products, we consider it prudent to cease taking these products
• Remember that obesity increases the risk of renal stones, as does weight loss 
achieved with laxatives or extreme dieting
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Practice tip
• Patients should maintain a normal 
calcium intake as recommended for 
age. Both a low and an excessively 
high calcium intake increase the risk 
of stone formation. 
Protein intake 
High protein diets (more than 2g/kg) should 
be avoided. High protein diets increase the 
urinary excretion of calcium and uric acid 
as well as reducing citrate excretion.20
Practice tip
• In general, reducing total protein 
intake and increasing fruit and 
 vegetable consumption will reduce 
the risk of stone formation. 
Excess uric acid 
Uric acid renal stones may form in patients 
with elevated urinary uric acid excretion 
associated with gout and elevated serum 
uric acid levels, and also in patients with 
normal serum uric acid levels but high 
tubular leaks of uric acid. A higher risk of 
uric acid stones has also been observed in 
patients with obesity, diabetes or metabolic 
syndrome. In patients with these condi-
tions, the urine is abnormally acidic.
Dietary management of people who 
develop uric acid stones has changed in 
recent years. Although uric acid is the major 
end-product of purine metabolism, restrict-
ing dietary purines does not appear to 
decrease the risk of uric acid renal stones. 
The major contributing factor to uric acid 
stone formation is low urinary pH (less 
than 5.5) rather than elevated urinary uric 
acid (hyperuricosuria).
A high fluid intake (more than 2.5 L/day) 
combined with a moderate protein intake 
(0.8 g/kg/day) and no alcohol have been 
shown to decrease urinary uric acid excre-
tion in adults.
Allopurinol is indicated for patients with 
persistently high urinary urate levels who 
develop urate stones and also those who 
develop predominantly calcium stones, as 
urate crystals may form the nidus around 
which calcium is then deposited. 
Oxalate
Hyperoxaluria may be genetic (primary), 
which is quite rare, or acquired. We recom-
mend managing patients with genetic 
hyperoxaluria and those with acquired 
hyperoxaluria and frequent stone forma-
tion at a dedicated stone clinic. For most 
patients with persistent hyperoxaluria, 
restricting dietary oxalate is reasonable, 
although evidence supporting such an 
approach is limited. Foods that should be 
limited include:
• green leafy vegetables (spinach, 
 silverbeet, kale, rocket, broccoli, 
beetroot, rhubarb and Chinese 
vegetables)
• legumes (soy beans and soy products 
such as soy sauce, tofu and tempeh, 
baked beans)
• nuts and nut products such as peanut 
butter 
• fruits such as berries and kiwifruit 
• products rich in dried fruit  
and peel such as marmalade or  
fruit cake
• cocoa-based products such as 
 chocolate and chocolate–malt drinks
• vegetable and fruit juices containing 
combinations such as spinach and 
beetroot or berries.
Patients who develop oxalate stones 
may also have reduced levels of a gastro-
intestinal bacterium that breaks down 
oxalate, Oxalobacter formigenes. The 
implications of this finding remain 
uncertain. 
Consultation with a dietitian is recom-
mended for patients on a low-oxalate diet 
to ensure adequate dietary variety. 
Practice tips
• Vitamin C in large doses may 
increase the risk of stone formation 
because of its conversion to oxalate. 
Vitamin C must not be taken by 
 anyone with genetic hyperoxaluria 
and is best avoided or at least limited 
to 500 mg/day by those with 
 nongenetic forms of hyperoxaluria.
• Patients should be advised to cook 
vegetables by boiling to reduce their 
oxalate content and to consume 
 calcium-rich foods with meals to 
help bind oxalate and reduce its 
absorption.21 This is because 
 individuals who develop  calcium 
oxalate stones appear to absorb 
 intestinal oxalate more readily than 
healthy individuals. 
Vitamins and other supplements
Vitamin C 
Vitamin C should be avoided by patients 
with hyperoxaluria, as discussed above. In 
addition, a prospective cohort study of 
Swedish men found that those taking 
 vitamin C supplements had double the risk 
of renal stone formation compared with 
those not taking vitamin C, suggesting 
a  need for caution with vitamin C 
supplementation.22
Vitamin D
Vitamin D supplementation may be a risk 
factor for renal stone disease. Several 
 studies have found a positive correlation 
between serum vitamin D levels and 
 urinary calcium excretion. This correla-
tion is probably a result of increased 
 intestinal calcium absorption, which 
increases intestinal absorption of 
oxalate. 
In granulomatous conditions such as 
sarcoidosis, vitamin D supplemen tation 
provides an additional substrate for 
 formation of 1,25-dihydroxyvitamin D 
and may result in hypercalcaemia as well 
as hypercalcuria and stone formation.
However, vitamin D deficiency can 
cause secondary hyperparathyroidism. 
We  recommend correcting vitamin D 
 deficiency and thus suppressing secondary 
hyper parathyroidism. In this situation we 
recom mend obtaining advice from a 
 specialised renal stone clinic and close 
 monitoring of urinary calcium excretion. 
Magnesium
Magnesium deficiency is associated with 
increased renal stone formation. Magne-
sium citrate may be taken by patients 
who develop stones because of impaired 
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absorption of calcium caused by small 
bowel disease. 
Fish oil supplements
Intake of omega-3 fatty acids such as 
 eicosapentaenoic acid (EPA) and docos-
ahexaenoic acid (DHA) may reduce the 
urinary excretion of calcium and oxalate. 
Thus, it has been suggested that a higher 
intake of EPA and DHA (from either 
 dietary sources or fish oil supplementa-
tion) may reduce the risk of renal stones; 
 however, no clinical trials have evaluated 
the effect of omega-3 fatty acids on the 
development of renal stones. Patients 
intending to take a fish oil product should 
check the labels carefully as some of these 
products contain vitamin D and may 
contribute to stone formation. 
Herbal and other botanical products 
Specific advice about herbal products and 
risk of stone formation is difficult because 
of a lack of information. However, if 
patients develop recurrent stones while 
using herbal or other botanical-based prod-
ucts, particularly herbal teas, the prudent 
advice is to cease taking these products. 
Obesity
Obesity is a risk factor for renal stone 
 formation, particularly in women. Obese 
patients have a higher incidence of uric 
acid stones. The metabolic syndrome is 
associated with a lower urinary pH. 
Bariatric surgery and certain types of 
weight loss diets may also increase the risk 
of renal stone formation. For example, a 
small study found that a low-carbohydrate, 
high-protein diet lowered urinary pH and 
citrate levels and increased urinary uric 
acid levels and acid and calcium excretion 
in healthy subjects. All of these changes 
increase the risk of stone formation and 
may increase the risk of bone loss. Excess 
sucrose intake is also linked with higher 
calcium excretion.
Practice tip
• Patients must be informed that losing 
weight with laxatives or extreme 




Bladder stones are usually composed of 
uric acid in non-infected urine or struvite 
in infected urine. Most patients with these 
types of stones have obstruction, which 
causes them to reduce their fluid intake, 
resulting in concentrated acidic urine. 
 Calcium oxalate or cystine stones form in 
the kidneys, pass down the ureter and are 
trapped in the bladder. 
Typical symptoms of bladder stones are 
intermittent, painful voiding and terminal 
haematuria. The pain may be dull, aching 
or sharp suprapubic pain, which is exacer-
bated by exercise and sudden movement. 
Severe pain typically occurs near the end 
of micturition when the stone becomes 
impacted at the bladder neck. This is 
relieved when the patient lies flat. Pain may 
be referred to the tip of the penis, scrotum, 
perineum and occasionally the back or hip. 
Impaction of the stone in the bladder neck 
interrupts the urinary stream. 
The main intervention for the preven-
tion of recurrent bladder stones is relief of 
bladder outlet obstruction. 
Infants
Neonates with frusemide-induced neph-
rolithiasis present with haematuria, 
 worsening renal function and calcific 
 densities on renal ultrasound or plain film 
radio graphy. Nephrocalcinosis is often 
present. Similar findings have been seen 
in  neonates with severe low birth weight 
and/or  prematurity and no history of loop 
diuretic usage.
Children and adolescents
The presence of stones in children and 
adolescents suggests the possibility of an 
inherited genetic disease such as cystinuria, 
renal tubular acidosis or primary oxaluria. 
With increasing obesity in childhood there 
is also an increase in the incidence of renal 
stones. 
The medical management is similar to 
that in adults with increased water intake. 
Dietary modifications are similar to adults 
except for calcium intake, which should be 
increased via dietary intake of high calcium 
foods rather than supplementation. 
Pregnant women
Pregnant women with renal stones should 
be imaged by ultrasound examination or 
MRI. Metabolic evaluation is not under-
taken during pregnancy. Management 
during pregnancy is generally surgical. 
Stents are inserted via cystoscopy with 
 minimal radiation. 
CONCLUSION
Renal stones are common. Stone recurrence 
can be avoided or reduced by addressing 
lifestyle and dietary factors. Referral for 
more detailed and specialised management 
to a specialised renal stone clinic is neces-
sary for some patients.   MT
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